Search

Search Constraints

You searched for: Author/Creator Jenkins, Robert B

Search Results

1. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

2. Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C. Issue 11 (9th May 2020)

3. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design. Issue 3 (17th July 2020)

4. Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor. Issue 11 (8th October 2019)

5. Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results: How Reflex Testing Settles the Score. Issue 5 (4th May 2021)

6. Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma. Issue 12 (8th September 2020)

7. Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas. Issue 1 (27th August 2020)

8. Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors. Issue 4 (1st November 2020)

9. H3 G34 mutation assessment for diffuse gliomas in adults: when would testing be most diagnostically useful?. Issue 1 (3rd November 2022)

10. Inherited genetics of adult diffuse glioma and polygenic risk scores—a review. Issue 4 (12th March 2022)